By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Critical Outcome Technologies Inc. 

The Stiller Centre for Biotechnology Commercialization
700 Collip Circle, Suite 213
London  Ontario  N6G 4X8  Canada
Phone: 519-858-5157 Fax: 519-858-5179


SEARCH JOBS


Industry
Pharmaceutical






Company News
Critical Outcome Technologies Inc. Announces Important New Mechanism of Action Data for COTI-2 9/20/2012 10:45:54 AM
Critical Outcome Technologies Inc. Initiates Final Toxicity Studies for COTI-2 9/18/2012 10:20:38 AM
Critical Outcome Technologies Inc. Receives U.S. Patent for Promising Oncology Compound COTI-2 10/13/2011 11:31:12 AM
Critical Outcome Technologies Inc. Announces Definitive Proof of COTI-2's Target and Single Agent Effectiveness from Critical Study 8/16/2011 11:33:19 AM
Critical Outcome Technologies Inc. Selected for Trade Mission to Biopartnering North America 2/23/2011 10:44:04 AM
Critical Outcome Technologies Inc. Updates Market 1/7/2011 8:29:31 AM
Critical Outcome Technologies Inc. Announces Refiling of Form 51-102F6 Statement of Executive Compensation 12/27/2010 9:54:28 AM
Critical Outcome Technologies Inc. Reports Fiscal 2011 Second Quarter Financial Results 12/10/2010 8:19:24 AM
Critical Outcome Technologies Inc. Announces Refiling of Annual Certificates 11/19/2010 11:53:43 AM
Critical Outcome Technologies Inc. Attending Bio-Europe to Meet with Prospective Partners for COTI-2 11/15/2010 2:44:33 PM
123456789
//-->